Abstract
Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories.
Keywords:
COVID-19; SARS-CoV-2; external quality assessment (EQA); laboratory preparedness; laboratory testing; molecular detection; novel coronavirus; outbreak control.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Betacoronavirus
-
COVID-19
-
COVID-19 Testing
-
COVID-19 Vaccines
-
Clinical Laboratory Services
-
Clinical Laboratory Techniques / methods*
-
Clinical Laboratory Techniques / standards*
-
Coronavirus / isolation & purification*
-
Coronavirus Infections / diagnosis*
-
Coronavirus Infections / epidemiology
-
Coronavirus Infections / virology
-
Disease Outbreaks
-
Europe
-
Humans
-
Molecular Diagnostic Techniques / methods*
-
Pandemics* / prevention & control
-
Pneumonia, Viral / diagnosis*
-
Pneumonia, Viral / epidemiology
-
Pneumonia, Viral / virology
-
Real-Time Polymerase Chain Reaction / standards
-
Reverse Transcriptase Polymerase Chain Reaction / standards
-
SARS-CoV-2
-
Sensitivity and Specificity
-
Surveys and Questionnaires